Annual CFI
$123.87 M
-$79.09 M-38.97%
31 December 2023
Summary:
Atara Biotherapeutics annual cash flow from investing activities is currently $123.87 million, with the most recent change of -$79.09 million (-38.97%) on 31 December 2023. During the last 3 years, it has risen by +$244.59 million (+202.60%). ATRA annual CFI is now -38.97% below its all-time high of $202.96 million, reached on 31 December 2022.ATRA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$16.66 M
-$23.86 M-331.59%
30 September 2024
Summary:
Atara Biotherapeutics quarterly cash flow from investing activities is currently -$16.66 million, with the most recent change of -$23.86 million (-331.59%) on 30 September 2024. Over the past year, it has dropped by -$87.11 million (-123.66%). ATRA quarterly CFI is now -123.66% below its all-time high of $70.45 million, reached on 30 September 2023.ATRA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$15.19 M
-$87.11 M-85.15%
30 September 2024
Summary:
Atara Biotherapeutics TTM cash flow from investing activities is currently $15.19 million, with the most recent change of -$87.11 million (-85.15%) on 30 September 2024. Over the past year, it has dropped by -$149.95 million (-90.80%). ATRA TTM CFI is now -92.51% below its all-time high of $202.96 million, reached on 31 December 2022.ATRA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -39.0% | -123.7% | -90.8% |
3 y3 years | +202.6% | -1495.7% | +56.8% |
5 y5 years | +163.1% | +71.5% | -85.6% |
ATRA Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -39.0% | +202.6% | -123.7% | +31.5% | -92.5% | +56.8% |
5 y | 5 years | -39.0% | +163.1% | -123.7% | +87.2% | -92.5% | +110.2% |
alltime | all time | -39.0% | +156.3% | -123.7% | +93.3% | -92.5% | +105.9% |
Atara Biotherapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$16.66 M(-331.6%) | $15.19 M(-85.2%) |
June 2024 | - | $7.20 M(-51.1%) | $102.30 M(-29.2%) |
Mar 2024 | - | $14.72 M(+48.0%) | $144.59 M(+16.7%) |
Dec 2023 | $123.87 M(-39.0%) | $9.94 M(-85.9%) | $123.87 M(-25.0%) |
Sept 2023 | - | $70.45 M(+42.4%) | $165.14 M(+7.0%) |
June 2023 | - | $49.48 M(-923.7%) | $154.39 M(+12.9%) |
Mar 2023 | - | -$6.01 M(-111.7%) | $136.73 M(-32.6%) |
Dec 2022 | $202.96 M(+811.8%) | $51.22 M(-14.2%) | $202.96 M(+59.3%) |
Sept 2022 | - | $59.70 M(+87.6%) | $127.41 M(+84.9%) |
June 2022 | - | $31.83 M(-47.1%) | $68.91 M(-0.1%) |
Mar 2022 | - | $60.22 M(-347.6%) | $68.97 M(+209.9%) |
Dec 2021 | $22.26 M(-118.4%) | -$24.32 M(-2137.2%) | $22.26 M(+129.7%) |
Sept 2021 | - | $1.19 M(-96.3%) | $9.69 M(-39.7%) |
June 2021 | - | $31.89 M(+136.2%) | $16.06 M(-111.0%) |
Mar 2021 | - | $13.50 M(-136.6%) | -$146.20 M(+21.1%) |
Dec 2020 | -$120.73 M(-299.7%) | -$36.89 M(-587.9%) | -$120.73 M(+46.0%) |
Sept 2020 | - | $7.56 M(-105.8%) | -$82.71 M(-44.4%) |
June 2020 | - | -$130.37 M(-434.5%) | -$148.79 M(-567.4%) |
Mar 2020 | - | $38.97 M(+3358.1%) | $31.84 M(-47.3%) |
Dec 2019 | $60.46 M(-130.8%) | $1.13 M(-101.9%) | $60.46 M(-42.6%) |
Sept 2019 | - | -$58.52 M(-216.4%) | $105.40 M(-39.9%) |
June 2019 | - | $50.25 M(-25.7%) | $175.35 M(+44.7%) |
Mar 2019 | - | $67.60 M(+46.7%) | $121.22 M(-161.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | -$196.29 M(-296.5%) | $46.07 M(+302.8%) | -$196.29 M(-1.6%) |
Sept 2018 | - | $11.44 M(-395.0%) | -$199.39 M(-2.4%) |
June 2018 | - | -$3.88 M(-98.4%) | -$204.21 M(+8.6%) |
Mar 2018 | - | -$249.92 M(-681.6%) | -$188.03 M(-288.2%) |
Dec 2017 | $99.91 M(+19.3%) | $42.97 M(+549.6%) | $99.91 M(+25.3%) |
Sept 2017 | - | $6.62 M(-46.2%) | $79.73 M(-26.3%) |
June 2017 | - | $12.30 M(-67.6%) | $108.15 M(-2.5%) |
Mar 2017 | - | $38.02 M(+66.9%) | $110.90 M(+32.4%) |
Dec 2016 | $83.74 M(-138.0%) | $22.79 M(-35.0%) | $83.74 M(+101.6%) |
Sept 2016 | - | $35.04 M(+132.7%) | $41.53 M(-128.4%) |
June 2016 | - | $15.06 M(+38.6%) | -$146.39 M(-25.2%) |
Mar 2016 | - | $10.86 M(-155.9%) | -$195.83 M(-11.0%) |
Dec 2015 | -$220.13 M(+164.1%) | -$19.42 M(-87.3%) | -$220.13 M(-14.6%) |
Sept 2015 | - | -$152.89 M(+344.6%) | -$257.64 M(+142.6%) |
June 2015 | - | -$34.39 M(+156.0%) | -$106.19 M(+42.8%) |
Mar 2015 | - | -$13.43 M(-76.4%) | -$74.38 M(-10.8%) |
Dec 2014 | -$83.36 M(>+9900.0%) | -$56.94 M(+3864.8%) | -$83.36 M(+215.4%) |
Sept 2014 | - | -$1.44 M(-44.3%) | -$26.43 M(+5.7%) |
June 2014 | - | -$2.58 M(-88.5%) | -$24.99 M(>+9900.0%) |
Mar 2014 | - | -$22.41 M(<-9900.0%) | -$3000.00(0.0%) |
Dec 2013 | -$3000.00 | $0.00(0.0%) | -$3000.00(0.0%) |
Sept 2013 | - | $0.00(-100.0%) | -$3000.00(0.0%) |
June 2013 | - | $22.41 M(-200.0%) | -$3000.00(-100.0%) |
Mar 2013 | - | -$22.41 M | -$22.41 M |
FAQ
- What is Atara Biotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual CFI year-on-year change?
- What is Atara Biotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly CFI year-on-year change?
- What is Atara Biotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM CFI year-on-year change?
What is Atara Biotherapeutics annual cash flow from investing activities?
The current annual CFI of ATRA is $123.87 M
What is the all time high annual CFI for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual cash flow from investing activities is $202.96 M
What is Atara Biotherapeutics annual CFI year-on-year change?
Over the past year, ATRA annual cash flow from investing activities has changed by -$79.09 M (-38.97%)
What is Atara Biotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ATRA is -$16.66 M
What is the all time high quarterly CFI for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly cash flow from investing activities is $70.45 M
What is Atara Biotherapeutics quarterly CFI year-on-year change?
Over the past year, ATRA quarterly cash flow from investing activities has changed by -$87.11 M (-123.66%)
What is Atara Biotherapeutics TTM cash flow from investing activities?
The current TTM CFI of ATRA is $15.19 M
What is the all time high TTM CFI for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM cash flow from investing activities is $202.96 M
What is Atara Biotherapeutics TTM CFI year-on-year change?
Over the past year, ATRA TTM cash flow from investing activities has changed by -$149.95 M (-90.80%)